PRTG
NASDAQ
Portage Biotech Inc. - Common Stock
Healthcare
· Biotechnology
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$19.3M
ROE
-674.0%
D/E
2.00
Beta
0.65
52W
$3–$23
Fundamentals Trend
| Metric | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2025-03-31 | 2025-09-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -232.8% | -170.3% | -267.7% | -674.0% | — | -674.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.86 | 1.17 | 1.47 | 2.00 | — | 2.00 |
| Current Ratio | 2.78 | 2.67 | 1.73 | 3.08 | 2.02 | 3.08 |
Key Ratios
ROA (TTM)
-415.6%
P/B
2.7
EPS (TTM)
$-64.27
CF/Share
$-6.27
52W High
$23.01
52W Low
$2.81
How does PRTG compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PRTG valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
2.7
▲
11%
above
peers
(2.5)
vs Peers
vs Industry
Fair value
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PRTG profitability vs Biotechnology peers
ROE
-674.0%
▼
901%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-415.6%
▼
790%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
PRTG financial health vs Biotechnology peers
D/E ratio
2.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
3.1
▼
31%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.7
▼
33%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
PRTG fundamentals radar
PRTG
Peer median
Industry
PRTG profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PRTG vs peers: key metrics
Latest News
No related news yet